EUVIMEDEUVIMED entdecken
Crossref

Formulation and Characterization of Nanocochleate-Based Drug Delivery System for Enhanced Oral Bioavailability

Ranveer Singh, Sandeep Kumar, Saurabh Sharma, Rizwan Ahmad, Darakhshan G. Bari

International Journal of Drug Delivery Technology · 30.04.2026 · 16 (41s)

DOI: 10.25258/ijddt.16.41s.26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.04.2026. Verfasst von Ranveer Singh und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Docetaxel is a potent anticancer drug with poor aqueous solubility, low oral bioavailability, and stability issues,limiting its therapeutic effectiveness. Nanocochleate-based lipid carriers offer a promising approach toovercome these limitations by enhancing drug stability, protection, and controlled release. Docetaxel-loadedliposomes were prepared using the thin film hydration method and optimized using Box–Behnken design byvarying DSPC and cholesterol concentrations. The optimized liposomal formulation was further converted intonanocochleates using calcium chloride via a trapping method. The formulations were evaluated for drug content,entrapment efficiency, in vitro drug release, particle size, zeta potential, FTIR, TEM, and stability studies. Theoptimized liposomal formulation (F8) showed high drug content (96.55%), entrapment efficiency (89.56%), anddrug release (92.68%). The optimized nanocochleate formulation (NF8) exhibited drug content of 95.89%,entrapment efficiency of 89.17%, and sustained drug release of 92.34%. Particle size analysis confirmednanoscale size with good stability. FTIR showed no interaction, and TEM confirmed well-definednanostructures. Drug release followed Higuchi kinetics, indicating diffusion-controlled release. Stability studiesdemonstrated minimal changes over three months. Nanocochleate-based delivery systems significantly improvethe solubility, stability, and controlled release of Docetaxel, making them a promising strategy for enhancingoral bioavailability and therapeutic efficacy.

Zitieren

APA

Singh, R., Kumar, S., Sharma, S., Ahmad, R., & Bari, D. G. (2026). Formulation and Characterization of Nanocochleate-Based Drug Delivery System for Enhanced Oral Bioavailability. International Journal of Drug Delivery Technology, 16(41s). https://doi.org/10.25258/ijddt.16.41s.26

Vancouver

Singh R, Kumar S, Sharma S, Ahmad R, Bari DG. Formulation and Characterization of Nanocochleate-Based Drug Delivery System for Enhanced Oral Bioavailability. International Journal of Drug Delivery Technology. 2026;16(41s). doi:10.25258/ijddt.16.41s.26

BibTeX
@article{Singh2026,
  author = {Singh, Ranveer and Kumar, Sandeep and Sharma, Saurabh and Ahmad, Rizwan and Bari, Darakhshan G.},
  title = {Formulation and Characterization of Nanocochleate-Based Drug Delivery System for Enhanced Oral Bioavailability},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {41s},
  doi = {10.25258/ijddt.16.41s.26}
}
Kostenlos starten →